Alerts will be sent to your verified email
Verify EmailFRANKLININD
Franklin Industries
|
Biogen Pharmachem
|
Aeonx Digital Techno
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
15.91 % | 0.21 % | 0.58 % |
5yr average Equity Multiplier
|
2.12 | 1.01 | 1.39 |
5yr Average Asset Turnover Ratio
|
1.95 | 0.02 | 0.71 |
5yr Avg Net Profit Margin
|
4.47 % | -19.83 % | 6.64 % |
Price to Book
|
0.95 | 1.1 | 1.22 |
P/E
|
3.25 | 0.0 | 10.94 |
5yr Avg Cash Conversion Cycle
|
41.88 Days | 0.0 | -19.38 Days |
Inventory Days
|
14.53 Days | 0.0 | 13.63 Days |
Days Receivable
|
80.91 Days | 0.0 | 158.91 Days |
Days Payable
|
89.3 Days | 1109.22 Days | 237.73 Days |
5yr Average Interest Coverage Ratio
|
91.56 | 902.8 | 6.89 |
5yr Avg ROCE
|
29.97 % | 0.21 % | 1.45 % |
5yr Avg Operating Profit Margin
|
7.0 % | -19.88 % | -6.73 % |
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.06 |
5yr CAGR Net Profit
|
204.43 % | n/a | n/a |
5yr Average Return on Assets
|
8.95 % | 0.21 % | 1.08 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 0.0 | 54.76 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.05 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Franklin Industries
|
Biogen Pharmachem
|
Aeonx Digital Techno
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|